ClearAlpha Technologies LP Sells 327 Shares of HCA Healthcare, Inc. (NYSE:HCA)

ClearAlpha Technologies LP reduced its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 23.7% in the third quarter, according to its most recent filing with the SEC. The institutional investor owned 1,054 shares of the company’s stock after selling 327 shares during the period. ClearAlpha Technologies LP’s holdings in HCA Healthcare were worth $428,000 as of its most recent filing with the SEC.

Several other hedge funds also recently modified their holdings of HCA. Atria Investments Inc purchased a new position in HCA Healthcare during the 1st quarter worth $1,379,000. Cetera Investment Advisers increased its position in shares of HCA Healthcare by 205.2% during the first quarter. Cetera Investment Advisers now owns 18,753 shares of the company’s stock valued at $6,255,000 after acquiring an additional 12,608 shares during the last quarter. Cetera Advisors LLC boosted its position in HCA Healthcare by 37.3% in the first quarter. Cetera Advisors LLC now owns 7,049 shares of the company’s stock worth $2,351,000 after purchasing an additional 1,916 shares during the last quarter. GAMMA Investing LLC raised its stake in shares of HCA Healthcare by 18.8% during the 2nd quarter. GAMMA Investing LLC now owns 1,290 shares of the company’s stock worth $414,000 after purchasing an additional 204 shares during the period. Finally, Massmutual Trust Co. FSB ADV grew its position in HCA Healthcare by 40.5% during the second quarter. Massmutual Trust Co. FSB ADV now owns 392 shares of the company’s stock valued at $126,000 after buying an additional 113 shares during the period. Hedge funds and other institutional investors own 62.73% of the company’s stock.

HCA Healthcare Trading Up 0.5 %

Shares of NYSE HCA opened at $327.22 on Monday. HCA Healthcare, Inc. has a 52-week low of $246.60 and a 52-week high of $417.14. The company has a market cap of $82.88 billion, a PE ratio of 14.69, a P/E/G ratio of 1.26 and a beta of 1.68. The firm’s 50 day moving average price is $371.88 and its 200-day moving average price is $358.84. The company has a debt-to-equity ratio of 48.71, a quick ratio of 1.00 and a current ratio of 1.12.

HCA Healthcare Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Friday, December 13th will be issued a dividend of $0.66 per share. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.81%. The ex-dividend date is Friday, December 13th. HCA Healthcare’s payout ratio is currently 11.85%.

Analyst Ratings Changes

HCA has been the subject of a number of research reports. Royal Bank of Canada increased their target price on shares of HCA Healthcare from $378.00 to $405.00 and gave the company an “outperform” rating in a research report on Friday, August 23rd. Truist Financial upped their price target on shares of HCA Healthcare from $390.00 to $430.00 and gave the company a “buy” rating in a research note on Monday, August 19th. Cantor Fitzgerald restated an “overweight” rating and set a $392.00 target price on shares of HCA Healthcare in a research report on Tuesday, October 1st. TD Cowen dropped their price target on HCA Healthcare from $450.00 to $440.00 and set a “buy” rating for the company in a research report on Monday, October 28th. Finally, KeyCorp lowered their price objective on shares of HCA Healthcare from $475.00 to $420.00 and set an “overweight” rating for the company in a report on Monday, October 28th. One research analyst has rated the stock with a sell rating, five have issued a hold rating, twelve have given a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat, HCA Healthcare presently has an average rating of “Moderate Buy” and an average price target of $380.29.

Insiders Place Their Bets

In other news, insider Erol R. Akdamar sold 2,900 shares of the company’s stock in a transaction dated Thursday, November 14th. The shares were sold at an average price of $353.00, for a total transaction of $1,023,700.00. Following the completion of the sale, the insider now owns 6,843 shares of the company’s stock, valued at $2,415,579. This represents a 29.76 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, SVP Phillip G. Billington sold 3,897 shares of HCA Healthcare stock in a transaction on Thursday, November 14th. The stock was sold at an average price of $350.00, for a total transaction of $1,363,950.00. Following the transaction, the senior vice president now owns 52,702 shares in the company, valued at $18,445,700. This represents a 6.89 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 15,155 shares of company stock valued at $5,608,990. 1.60% of the stock is owned by insiders.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.